Ebos Group Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, consumer, and animal care products in Australia and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and multi-brand retail pharmacy services. It also offers vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; community based health care services and programs; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers contract logistics services, such as healthcare distribution, warehousing, clinical trial management, and product registration services; and clinical trial logistics. Additionally, the company provides pet nutrition products, treats, clean-up products, grooming, and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
|Primary activities||Diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products.|
|Industry / Sector||Medical Distribution / Healthcare|
|Full time employees||5000|
|Mailing address||737 Bourke Street Level 7 Docklands VIC 3008 Australia|
|Phone / Fax||61 3 9918 5555 / 61 3 9918 5599|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY. LIMITED|
5Y Avg. yield
Ebos Group paid $0.88 dividend and the ex-dividend date was 08 Sept 2022.The dividend payout ratio is 65.65%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.EBO dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
EBO's forward dividend amount is $0.76 and the forward dividend yield is 2.31%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Oct 2022, following are the company executives and directors listed on Ebos Group.
|Mr. John Cullity||Chief Exec. Officer||3.24M|
|Mr. Leonard Hansen||CFO & Chief Accountant|
|Ms. Andrea Bell||Chief Information Officer|
|Martin Krauskopf||Exec. GM of Strategy, Mergers & Acquisitions and GM of Investor Relations|
|Ms. Janelle Cain||Gen. Counsel|
|Ms. Jacinta McCarthy||Group Gen. Mang. of HR|
|Mr. Simon Bunde||Exec. Gen. Mang. of Strategic Operations, ESG & Innovation|
|Ms. Julie Dillon||Chief Exec. Officer of Animal Care|
|Mr. Matthew Muscio||Chief Exec. Officer of Medical Technology|
|Mr. Brett Barons||Chief Exec. Officer of Symbion|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Ebos Group is and its enterprise value is .
The EBO's stocks Beta value is 0.37 making it 63% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Ebos Group (EBO)
- Ansell (ANN)
- Cochlear (COH)
- Fisher & Paykel Healthcare Corporation (FPH)
- Estia Health (EHE)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Resmed Inc (RMD)
- Ramsay Health Care (RHC)
- Polynovo (PNV)
- Sonic Healthcare (SHL)
Ebos Group (ASX:EBO) Frequently Asked Questions
1. What is Ebos Group's Stock Symbol?
Ebos Group trades on ASX under the ticker symbol "EBO".
2. What is Ebos Group's stock price today?
One share of EBO stock can currently be purchased for approximately $33.2.
3. How can I contact Ebos Group?
Ebos Group's mailing address is 737 Bourke Street Level 7 Docklands VIC 3008 Australia. The company can be reached via phone at 61 3 9918 5555.
4. What is Ebos Group's official website?
The official website of Ebos Group is https://www.ebosgroup.com.
5. Which share registry manages Ebos Group's stock?
Ebos Group's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY. LIMITED.